Pacific Biosciences of California (PACB) Competitors $1.37 -0.02 (-1.44%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$1.37 0.00 (0.00%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACB vs. TXG, HBIO, TMO, A, MTD, WAT, ILMN, TECH, CRL, and BIOShould you be buying Pacific Biosciences of California stock or one of its competitors? The main competitors of Pacific Biosciences of California include 10x Genomics (TXG), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), and Bio-Rad Laboratories (BIO). Pacific Biosciences of California vs. Its Competitors 10x Genomics Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bio-Rad Laboratories 10x Genomics (NASDAQ:TXG) and Pacific Biosciences of California (NASDAQ:PACB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Which has more risk and volatility, TXG or PACB? 10x Genomics has a beta of 2.03, suggesting that its stock price is 103% more volatile than the S&P 500. Comparatively, Pacific Biosciences of California has a beta of 2.16, suggesting that its stock price is 116% more volatile than the S&P 500. Do institutionals & insiders believe in TXG or PACB? 84.7% of 10x Genomics shares are held by institutional investors. 10.0% of 10x Genomics shares are held by company insiders. Comparatively, 2.4% of Pacific Biosciences of California shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is TXG or PACB more profitable? 10x Genomics has a net margin of -25.14% compared to Pacific Biosciences of California's net margin of -430.93%. 10x Genomics' return on equity of -23.22% beat Pacific Biosciences of California's return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-25.14% -23.22% -18.02% Pacific Biosciences of California -430.93%-52.07%-15.82% Do analysts recommend TXG or PACB? 10x Genomics presently has a consensus target price of $14.13, indicating a potential upside of 16.26%. Pacific Biosciences of California has a consensus target price of $2.06, indicating a potential upside of 50.45%. Given Pacific Biosciences of California's higher possible upside, analysts clearly believe Pacific Biosciences of California is more favorable than 10x Genomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 1 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.46Pacific Biosciences of California 0 Sell rating(s) 5 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.44 Which has preferable earnings and valuation, TXG or PACB? 10x Genomics has higher revenue and earnings than Pacific Biosciences of California. 10x Genomics is trading at a lower price-to-earnings ratio than Pacific Biosciences of California, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.78M2.45-$182.63M-$1.30-9.35Pacific Biosciences of California$154.01M2.67-$309.85M-$2.79-0.49 Does the media favor TXG or PACB? In the previous week, 10x Genomics had 4 more articles in the media than Pacific Biosciences of California. MarketBeat recorded 5 mentions for 10x Genomics and 1 mentions for Pacific Biosciences of California. Pacific Biosciences of California's average media sentiment score of 1.01 beat 10x Genomics' score of 0.44 indicating that Pacific Biosciences of California is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Pacific Biosciences of California 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Summary10x Genomics beats Pacific Biosciences of California on 10 of the 16 factors compared between the two stocks. Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACB vs. The Competition Export to ExcelMetricPacific Biosciences of CaliforniaMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$411.12M$6.65B$5.53B$9.41BDividend YieldN/A1.33%4.00%4.04%P/E Ratio-0.4925.6528.2519.76Price / Sales2.6762.29412.5889.28Price / CashN/A20.4724.9928.17Price / Book0.744.618.095.69Net Income-$309.85M$176.14M$3.25B$257.97M7 Day Performance-6.80%0.40%1.63%3.74%1 Month Performance7.87%2.96%7.62%11.95%1 Year Performance-17.47%3.10%32.74%19.22% Pacific Biosciences of California Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACBPacific Biosciences of California1.7051 of 5 stars$1.37-1.4%$2.06+50.4%-17.5%$411.12M$154.01M-0.49730Positive NewsGap UpTXG10x Genomics4.5465 of 5 stars$12.47-2.6%$14.13+13.3%-27.2%$1.54B$624.66M-9.591,240News CoverageAnalyst RevisionHBIOHarvard Bioscience4.2436 of 5 stars$0.43-3.2%$3.00+596.7%-85.4%$19.04M$91.40M-0.33490Gap UpTMOThermo Fisher Scientific4.9885 of 5 stars$425.44-2.2%$600.30+41.1%-22.3%$160.60B$42.90B24.95125,000Trending NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionAAgilent Technologies4.848 of 5 stars$120.10-2.6%$139.77+16.4%-13.5%$34.12B$6.51B29.6517,900Positive NewsMTDMettler-Toledo International4.0465 of 5 stars$1,195.06-2.4%$1,280.90+7.2%-10.9%$24.84B$3.83B29.8017,300Positive NewsWATWaters4.9046 of 5 stars$303.93-13.9%$388.94+28.0%-5.1%$18.09B$2.98B27.587,600Trending NewsAnalyst DowngradeAnalyst RevisionHigh Trading VolumeILMNIllumina4.887 of 5 stars$98.53-0.7%$125.11+27.0%-16.0%$15.60B$4.37B-16.239,030Analyst RevisionTECHBio-Techne4.86 of 5 stars$52.62-2.8%$70.00+33.0%-31.1%$8.25B$1.16B64.173,100Analyst RevisionCRLCharles River Laboratories International4.7579 of 5 stars$158.09-0.8%$174.54+10.4%-29.2%$7.77B$4.05B-243.2120,100Positive NewsBIOBio-Rad Laboratories4.7334 of 5 stars$250.92-2.4%$324.25+29.2%-17.0%$6.83B$2.54B-3.297,700 Related Companies and Tools Related Companies TXG Competitors HBIO Competitors TMO Competitors A Competitors MTD Competitors WAT Competitors ILMN Competitors TECH Competitors CRL Competitors BIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PACB) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PACB Stock Alerts